Sarah V. Colonna

Oncology

1950 Circle Of Hope Dr
Salt Lake City, UT 84112

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Cluster randomized controlled trial of decision support for breast cancer chemoprevention, MiCHOICE.

Cluster randomized controlled trial of decision support for breast cancer chemoprevention, MiCHOICE.

Journal: Journal of the National Cancer Institute

Published: February 28, 2026

NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate, Version 2.2026.

NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate, Version 2.2026.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: February 11, 2026

The Clinical Application of Refined Risk Estimates (caRe) Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial.

The Clinical Application of Refined Risk Estimates (caRe) Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial.

Journal: Cancer prevention research (Philadelphia, Pa.)

Published: February 04, 2026

Prevalence of Veteran-reported treatment barriers from the breast and gynecologic oncology system of excellence.

Prevalence of Veteran-reported treatment barriers from the breast and gynecologic oncology system of excellence.

Journal: Cancer epidemiology

Published: January 09, 2026

Characteristics of women Veterans with incident breast and gynecologic cancers in the Veterans Health Administration.

Characteristics of women Veterans with incident breast and gynecologic cancers in the Veterans Health Administration.

Journal: Women's health (London, England)

Published: December 24, 2025

Prevalence of Toxic Exposures Among Women Veterans With Breast or Gynecologic Cancers Receiving Veterans Affairs (VA) Care.

Prevalence of Toxic Exposures Among Women Veterans With Breast or Gynecologic Cancers Receiving Veterans Affairs (VA) Care.

Journal: Military medicine

Published: November 21, 2025

Risks of non-breast, non-ovarian cancers for BRCA1 and BRCA2 pathogenic variant carriers: a prospective cohort study.

Risks of non-breast, non-ovarian cancers for BRCA1 and BRCA2 pathogenic variant carriers: a prospective cohort study.

Journal: BMC medicine

Published: September 13, 2025

Threshold-Based Overlap of Breast Cancer High-Risk Classification Using Family History, Polygenic Risk Scores, and Traditional Risk Models in 180,398 Women.

Threshold-Based Overlap of Breast Cancer High-Risk Classification Using Family History, Polygenic Risk Scores, and Traditional Risk Models in 180,398 Women.

Journal: Cancers

Published: September 09, 2025

Using Open-Source Large Language Models to Identify Access to Germline Genetic Testing in Veterans With Breast Cancer From Unstructured Text.

Using Open-Source Large Language Models to Identify Access to Germline Genetic Testing in Veterans With Breast Cancer From Unstructured Text.

Journal: JCO clinical cancer informatics

Published: July 22, 2025

Overlap of high-risk individuals across family history, genetic & non-genetic breast cancer risk models: Analysis of 180,398 women from European & Asian ancestries.

Overlap of high-risk individuals across family history, genetic & non-genetic breast cancer risk models: Analysis of 180,398 women from European & Asian ancestries.

Journal: medRxiv : the preprint server for health sciences

Published: March 17, 2025

Importance of Prior Patient Interactions With the Healthcare System to Engaging With Pretest Cancer Genetic Services via Digital Health Tools Among Unaffected Primary Care Patients: Findings From the BRIDGE Trial.

Importance of Prior Patient Interactions With the Healthcare System to Engaging With Pretest Cancer Genetic Services via Digital Health Tools Among Unaffected Primary Care Patients: Findings From the BRIDGE Trial.

Journal: Health services research

Published: November 10, 2024

Uptake of Cancer Genetic Services for Chatbot vs Standard-of-Care Delivery Models: The BRIDGE Randomized Clinical Trial.

Uptake of Cancer Genetic Services for Chatbot vs Standard-of-Care Delivery Models: The BRIDGE Randomized Clinical Trial.

Journal: JAMA network open

Published: September 09, 2024

Showing 1-12 of 47

Last Updated: 09/26/2026